A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Having prescription records of palbociclib from 15 December 2017 to 29 February 2024.
Having any breast cancer records in same month as the first prescription date.
You may not be if
Having an ANC less than the threshold value for grade 4 neutropenia within 30 days of the first prescription of palbociclib
Having any records of anti-HER2 medication
Clareo Health | A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)
